By: Jason D. Bloom, MD; Sachin M. Shridharani, MD
This course has expired. You can still review the content but course credit is no longer available.
When it comes to minimally-invasive facial rejuvenation, what's possible with today's tools? What's expected? What's appropriate? Sachin M. Shridharani, MD and Jason D. Bloom, MD outline principles of facial aesthetics, discuss important anatomical considerations, review data about patient expectations, and outline effective approaches to full-face rejuvenation.
Supported by a educational grant from Allergan.
Upon completion of this activity, the participant should be able to:
Accreditation Statement
Evolve Medical Education LLC is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
AMA Credit Designation Statement
Evolve Medical Education LLC designates this enduring activity for a maximum of 1 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
The following faculty members have the following financial relationships with commercial interests:
Jason D. Bloom, MD has had a financial agreement or affiliation during the past year with the following commercial interests in the form of Consultant/Advisory Board/Speaker’s Bureau: Allergan plc; Alma Lasers; Galderma Laboratories L.P.; InMode; Merz Pharma; Pharmaceutical Project Solutions (PPSI); Sinclair Pharma; and ThermiGen, LLC. Grant/Research Support: Allergan plc, Galderma Laboratories L.P.; and ZELTIQ Aesthetics, Inc. Stock/Shareholder: Cearna Inc.
Sachin Shridharani, MD has had a financial agreement or affiliation during the past year with the following commercial interests in the form of Consultant/Advisory Board/Speaker’s Bureau: Allergan plc; Galderma Laboratories L.P.; Merz Pharma; and Mira Mar, Inc. Grant/Research Support: Allergan plc.
Editorial Support Disclosure
Cheryl Cavanaugh, MS, Evolve Medical Education LLC and Anthony Rossi, Peer Reviewer have no real or apparent conflicts of interest to report.